Christ, Günter <br/><br/>
Platelet inhibition by abciximab bolus-only administration and oral ADP receptor antagonist loading in acute coronary syndrome patients: the blocking and bridging strategy.  [electronic resource] 

 -  Thrombosis research  Jul 2013 
 - e36-41 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article 
<br/><br/><label>ISSN: </label>1879-2472 
<br/><br/><label>Standard No.: </label>10.1016/j.thromres.2013.05.029  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abciximab<br/>Acute Coronary Syndrome--drug therapy<br/>Administration, Oral<br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--administration & dosage<br/>Blood Platelets<br/>Clopidogrel<br/>Drug Administration Routes<br/>Female<br/>Humans<br/>Immunoglobulin Fab Fragments--administration & dosage<br/>Male<br/>Middle Aged<br/>Piperazines--administration & dosage<br/>Platelet Aggregation--drug effects<br/>Platelet Aggregation Inhibitors--administration & dosage<br/>Platelet Function Tests<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Prasugrel Hydrochloride<br/>Purinergic P2Y Receptor Antagonists--administration & dosage<br/>Thiophenes--administration & dosage<br/>Ticlopidine--administration & dosage